Chemokines: agents for the immunotherapy of cancer?

Homey, Bernhard, Müller, Anja, Zlotnik, Albert·2002·Nature Reviews Immunology
DOI 10.1038/nri748

Cited by (398)

Items 301–398 of 398

  1. The Combination of Chemotherapy and Systemic Immunotherapy and the Concept of Cure in Murine Leukemia and Lymphoma
    Kyriaki Dunussi‐Joannopoulos · 2002 · Leukemia & lymphoma/Leukemia and lymphoma
  2. Telomere length sensitive regulation of interleukin receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment
    Ananda Kishore Mukherjee, Subhajit Dutta, Ankita Singh, Shalu Sharma, Shuvra Shekhar Roy, Antara Sengupta, Megha Chatterjee, Soujanya Vinayagamurthy, Sulochana Bagri, Divya Khanna et al. · 2024 · eLife
  3. Overexpression of ST8Sia1 inhibits tumor progression by TGF-β1 signaling in rectal adenocarcinoma and promotes the tumoricidal effects of CD8 + T cells by granzyme B and perforin
    Chang Zhang, Yeli Wang, Yu Yao, Yanchao Pang, Xiao Xiao, Leilei Hao · 2024 · Annals of Medicine
  4. Cutaneous T-Cell Lymphoma: Two Faces of the Same Coin
    Magdalena B. Wozniak, Miguel Angel Piris · 2010 · Journal of Investigative Dermatology
  5. Chemokine receptor CCR5 and CXCR4 might influence virus replication during IBDV infection
    Changbo Ou, Qiuxia Wang, Yan Ping Yu, Yanhong Zhang, Jinyou Ma, Xianghui Kong, Xingyou Liu · 2017 · Microbial Pathogenesis
  6. Development of novel avenues to overcome challenges facing CAR T cells
    Soyeon Kim, Edmund K. Moon · 2017 · Translational research
  7. Distinct Effects of Immunosuppressive Drugs on the Anti-Aspergillus Activity of Human Natural Killer Cells
    Stanislaw Schmidt, Ralf Schubert, Asuman Demir, Thomas Lehrnbecher · 2019 · Pathogens
  8. Developing DNA methylation‐based prognostic biomarkers of acute myeloid leukemia
    Chundi Gao, Jing Zhuang, Chao Zhou, Lijuan Liu, Cun Liu, Huayao Li, Minzhang Zhao, Gongxi Liu, Changgang Sun · 2018 · Journal of Cellular Biochemistry
  9. Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer
    Giorgio Mauri, Claudia Chiodoni, Mariella Parenza, Ivano Arioli, Claudio Tripodo, Mario P. Colombo · 2013 · Cancer Immunology Immunotherapy
  10. Telomere length sensitive regulation of interleukin receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment
    Ananda Kishore Mukherjee, Subhajit Dutta, Ankita Singh, Shalu Sharma, Shuvra Shekhar Roy, Antara Sengupta, Megha Chatterjee, Soujanya Vinayagamurthy, Sulochana Bagri, Divya Khanna et al. · 2024 · eLife
  11. Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas
    Hannah K. Jaeger, David A. Davis, Ashwin Nair, Prabha Shrestha, Alexandra Stream, Amulya Yaparla, Robert Yarchoan · 2023 · Scientific Reports
  12. Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T Cells in Cancer Immunotherapy
    Imran Siddiqui, Alberto Mantovani, Paola Allavena · 2014 · Springer eBooks
  13. Effect of Asbestos on Anti-Tumor Immunity and Immunological Alteration in Patients with Malignant Mesothelioma
    Yasumitsu Nishimura, Megumi Maeda, Naoko Kumagai-Takei, Hidenori Matsuzaki, Sai Peck Lee, Kazuya Fukuoka, Takashi Nakano, Takumi Kishimoto, Takemi Otsuki · 2012 · InTech eBooks
  14. Changes in T-lymphocytes in lung cancer patients after hyperthermic intraperitoneal chemotherapy or radiotherapy
    Lei Yan, M. Wu, Nan Ba, G. Shi, Ling-Rui Wang, H. Zhang · 2016 · Genetics and Molecular Research
  15. Inflammation
    M. Steinhoff, Christopher E.M. Griffiths, M. K. Church, T. A. Luger · 2004
  16. An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions
    Jialing Zhang, Stephan Stanislaw Späth, Sherman M. Weissman, Samuel G. Katz · 2019 · Methods in molecular biology
  17. iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration
    Tolga Turan, Sarah Kongpachith, Kyle D. Halliwill, Robert T. McLaughlin, Mikhail Binnewies, Dhemath Reddy, Xi Zhao, Rebecca S. Mathew, Shiming Ye, Howard J. Jacob et al. · 2023 · Cancer Immunology Research
  18. Development of Novel Anticancer Agents in Older Patients
    Anthony J. Murgo, Igor Espinoza‐Delgado · 2005 · The Cancer Journal
  19. Concepts and Ways to Amplify the Antitumor Immune Response
    Bent Rubin, Jean Edouard Gairin · 2010 · Current topics in microbiology and immunology
  20. Cytokine-Related Genes Identified From the RIKEN Full-Length Mouse cDNA Data Set
    Vladimir Brusić, Rekha S. Pillai, Diego G. Silva, Nikolai Petrovsky, RIKEN GER Group, GSL Members, Christian Schönbach · 2003 · Genome Research
  21. Effect of Korean Mistletoe Lectin on Gene Expression Profile in Human T Lymphocytes: A Microarray Study
    Su‐Yun Lyu, Won-Bong Park · 2010 · Biomolecules & Therapeutics
  22. Nano-selenium alleviated immunoresponse, apoptosis and oxidative stress in Leydig cells of yak
    Hao Li, Yujun Tang, Hui Wang, Xinyue Liu, Yutian Zeng, Run Zhang, Cuiting Yang, Arab Khan, Bing Wu, Xianxiang Wang et al. · 2025 · Colloids and Surfaces B Biointerfaces
  23. Chemokine receptors in tissue cells and angiogenesis
    Paola Romagnani, Laura Lasagni, Sergio Romagnani · 2006 · Birkhäuser-Verlag eBooks
  24. Molekularbiologische Erklärungsansätze einer Lymphknotenmetastasierung
    F. vom Dorp, Bernd Wullich, Erich Gulbins, A. Eisenhardt · 2005 · Der Urologe
  25. Molekularbiologische Aspekte von Lymphknotenmetastasen
    M. Schenck, Herbert Ruebben, Erich Gulbins · 2009 · Der Urologe
  26. Expression of cancer-associated molecules in malignant mesothelioma.
    Ben Davidson · 2007 · Europe PMC (PubMed Central)
  27. Role of CXC Chemokines and Receptors in Liver Metastasis – Impact on Liver Resection-Induced Engraftment and Tumor Growth
    Otto Kollmar, Michael Dieter Menger, Martin Karl Schilling · 2011 · Cancer metastasis
  28. Expression of Cancer-Associated Molecules in Malignant Mesothelioma
    Ben Davidson · 2007 · Biomarker Insights
  29. Molecular Genetic Markers in Female Reproductive Cancers
    Tian‐Li Wang, Ben Davidson, Phillip Buckhaults, Chiun‐Sheng Huang, Gudrun Pohl · 2010 · Journal of Oncology
  30. Immune Regulation in Neuroblastoma
    Stefan Fest, Sven Starke · 2015 · Pediatric and adolescent medicine
  31. Cancer and the Immune System
    Lisa Helene Butterfield, Stephen Philip Schoenberger, Jeffrey B. Lyczak · 2015 · ASM Press eBooks
  32. Inflammatory Mediators: Potential Drug Targets in Cancer
    Mükerrem Betül Yerer, Eren Demirpolat, İ. İpek Boşgelmez · 2020 · Springer eBooks
  33. Inflammation, Immunology and Allergy
    Martin S. Steinhoff · 2016
  34. Novel strategies for exploitation of milk glycoproteins for food ingredient applications
    Shane Feeney · 2019 · Arrow@dit (Dublin Institute of Technology)
  35. Myeloid derived suppressor cells in neuroblastoma: mechanisms of immune evasion and therapeutic opportunities
    Hae Soo Choo, Tina Yu, Timothy Pham, Neharika Singh, Shweta Joshi · 2026 · Frontiers in Immunology
  36. Stratification of Patients with Follicular Lymphoma
    H. Abd El -Ghaffar, Sameh Sayed Ahmed Shamaa, Nadia Attwan, Eman Tarek, K. Nashwa, Dalia Salem, Sherin M. Abd El-Aziz, M. Layla · 2012 · InTech eBooks
  37. Ovarian/Primary Peritoneal Carcinoma
    Ben Davidson · 2011 · Springer eBooks
  38. Proteases and Cancer Development
    Shudong Zhu, Zhoufang Li · 2013 · Springer eBooks
  39. Aspartic proteases: Potential drug targets for anticancer drug development
    Ankit Ganeshpurkar, Subhajit Makar, Devendra Kumar, Srabanti Jana, Sushil Kumar Singh · 2020 · Elsevier eBooks
  40. Immune Surveillance and Cancer Pathogenesis
    Domenico Mastrangelo · 2005 · Springer eBooks
  41. Selection and Monitoring of Patients for Immunotherapy (Peptide Vaccines)
    Xiao Liu, Justin Paul Kline · 2015 · Springer eBooks
  42. Retinal Metastases
    Sunil K. Srivastava, Chris S. Bergstrom · 2012 · Elsevier eBooks
  43. Research Progress on the Relationship between Inflammatory Factors and Tumor and Its Mechanism
    贺 徐 · 2021 · Advances in Clinical Medicine
  44. Treg, Chemokines, and Other Small Molecules: Role in Metastasis and Its Prevention
    Darryl A. Oble, Frank Stephen Hodi, Gregory Yves Lauwers, Glenn Dranoff, Martín C. Mihm · 2009 · Humana Press eBooks
  45. Macrophages in tumour development and metastasis
    Alexandra Eichten, Karin E. de Visser, Lisa M. Coussens · 2008 · Springer eBooks
  46. Role of Chemokines and Chemokine Receptors in Diseases of Ageing
    Erminia Mariani, Adriana Rita Mariani, Andrea Facchini · 2008 · Springer eBooks
  47. Gene expression changes in normal haematopoietic cells
    Jack M. Lionberger, Derek L. Stirewalt · 2009 · Best Practice & Research Clinical Haematology
  48. Rôle des interactions entre cellules stromales et leucocytaires dans les maladies articulaires inflammatoires chroniques
    Paul F. Bradfield, Andrew M. C. Thomas, Angela C. Burman, Oliver Haworth, Greg N. Parsonage, Andrew D. Filer, Nicole Amft, Mike Salmon, Christopher Dominic Buckley · 2004 · Revue du Rhumatisme
  49. Inflammation
    Martin S. Steinhoff, Richard W. Groves, Philip E. LeBoit, Thomas Anton Luger · 2010
  50. Telomere length sensitive regulation of Interleukin Receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment
    Ananda Kishore Mukherjee, Subhajit Dutta, Ankita Singh, Shalu Sharma, Shuvra Shekhar Roy, Antara Sengupta, Megha Chatterjee, Soujanya Vinayagamurthy, Sulochana Bagri, Divya Khanna et al. · 2024 · eLife
  51. Development of a Murine Model to Study Inhibitors of CXCR3-Ligand Interactions
    Charis Tjoeng · 2010 · D-Scholarship@Pitt (University of Pittsburgh)
  52. Immune Defects in Patients Suffering From Non-Hodgkin’s Lymphoma
    Thomas Zander, Daniel Ré, Michael von Bergwelt‐Baildon, Jürgen Wolf, Joachim Ludwig Schultze · 2004 · Humana Press eBooks
  53. Agonist and antagonist peptide ligands of CXCR4 receptor as marker for the anticancer drugs or diagnostic agents delivery
    Luca Monfregola · 2010 · Università degli Studi di Napoli Federico II
  54. TUMOUR IMMUNE THERAPY: THE BIRTH OF A NEW ARRAY OF CANCER TREATMENT STRATEGIES
    Farzin Farzaneh · 2002
  55. Interplay between inflammation and tumor angiogenesis
    Yan Li, Xiaoyu Song, Marian T. Nakada · 2004 · Birkhäuser Basel eBooks
  56. Quimioquinas, proteínas atractivas y promiscuas queempiezan a destacarse en el escenario de la inflamación y lainmunidad
    Rosa Wainstok · 2003
  57. The role of D6 in neutrophil migration, melanoma growth and metastasis
    Claire L. Burt · 2011 · Enlighten: Theses (The University of Glasgow)
  58. Expression, Signaltransduktion und biologische Funktionen des CCL20/CCR6-Chemokin-Ligand-Rezeptor-Systems in intestinalen Epithelzellen
    Torsten Olszak · 2007 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  59. Fusionieren Zellen des kleinzelligen Bronchialkarzinomes spontan mit humanen mesenchymalen Stammzellen aus dem Knochenmark
    Thorsten Derlin · 2009
  60. Einfluss mesenchymaler Stammzellen aus dem Fettgewebe auf das Invasionsverhalten muriner und humaner Brustkrebszellen
    Severin P. Pinilla · 2012 · BORIS (University Library Bern)
  61. Immune Surveillance and Cancer Pathogenesis
    Domenico Mastrangelo · 2014 · Springer eBooks
  62. [Immune anticancer response: recent advances in the treatment of renal cell carcinoma].
    Françoise Bouet, Véronique Catros · 2004 · PubMed
  63. Chemokines and Matrix Metalloproteinases in Colorectal Cancer
    Gayle G. Vaday, Stanley Zucker · 2006 · Kluwer Academic Publishers eBooks
  64. CANCER GENE THERAPY USING CYTOKINE AND CHEMOKINE GENES
    Naofumi Mukaida · 2004 · Annals of Cancer Research and Therapy
  65. Tratamiento con anticuerpos monoclonales
    Teresa Español · 2003 · Medicina Clínica
  66. Vectores adenovirales de primera generación, el vector por excelencia en inmunoterapia génica del cáncer
    Iñigo Narvaiza, Guillermo Daniel Mazzolini, Cheng Qian, Jesús Prìeto, Ignacio Melero · 2003 · Inmunología
  67. Importance of CXCL12 and CXCR4 in radiotherapy of head and neck cancer, considering the association with HPV-infection
    Narges Tehrany · 2015
  68. Aus der Medizinischen Klinik und Poliklinik II - Großhadern der Ludwig-Maximilians-Universität München Direktor: Prof. Dr. med. B. Göke Expression, Signaltransduktion und biologische Funktionen des CCL20/CCR6-Chemokin-Ligand-Rezeptor-Systems in intestinalen Epithelzellen
    Ludwig-Maximilians-Universität München · 2007
  69. Down-regulation of CXCR4 by Inducible Retrovirally Mediated RNA Interference Inhibits Human Cervix Carcinoma Cell Invasion in Vitro
    Hu Li · 2008 · Clinical Oncology and Cancer Research
  70. Breast Cancer Metastasis: Role of Tumor Microenvironment and Resident Macropahges
    Khemraj Singh Baghel, Smrati Bhadauria · 2016 · Defence Life Science Journal
  71. Análise da expressão gênica de NFKB1, TNF-α, e p38α na mucosa gástrica: relação com contaminação por Helicobacter pylori
    Henrique Sulzbach de Oliveira · 2015 · Americanae (AECID Library)
  72. Immature Myeloid Cells Promote Tumor Formation Via Non-Suppressive Mechanism
    Myrna L. Ortiz · 2014 · Digital Commons - University of South Florida (University of South Florida)
  73. THE ROLES OF CHEMOKINES, CHEMOKINE RECEPTORS AND GLYCOLIPID ACTIVATION IN NKT CELL TUMOUR INFILTRATION
    Natasa Zatezalo · 2017 · DalSpace (Dalhousie University)
  74. Cancer and the Immune System
    Jörg Blümel · 2015 · Springer eBooks
  75. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
    Hayriye Şahinli, Sema Türker · 2019 · Journal of Clinical Medicine of Kazakhstan
  76. THE CXCR7/CXCR4/CXCL12 AXIS IN HUMAN NEUROBLASTOMA: INVOLVEMENT IN MALIGNANT PROGRESSION
    Julie Liberman · 2012 · IRIS
  77. Effects of Vanadyl Sulfate and Newcastle Disease Virus (NDV) Combination Therapy in Murine Models of Cancer
    Thomas M. McAusland · 2020 · The Atrium (University of Guelph)
  78. Bioluminescent imaging of an NF-kB transgenic mouse model for monitoring immune response to a bioartificial pancreas real time and in vivo: validation of the method
    David J. Roth · 2005
  79. Other cells of the tumor microenvironment
    Doménico Ribatti · 2021 · Elsevier eBooks
  80. Ovarian/Primary Peritoneal Carcinoma
    Ben Davidson · 2011 · Springer eBooks
  81. Immunologic Approaches to Lung Cancer Therapy
    Jay M. Lee, Steven M. Dubinett, Sherven P. Sharma · 2008 · Lung Cancer
  82. Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T-Cells in Cancer Immunotherapy
    Imran Siddiqui, Debora Vignali, Marinos Kallikourdis, Alberto Mantovani, Paola Allavena · 2020 · Springer eBooks
  83. Cancer and the Immune System
    Jörg Blümel · 2014 · Springer eBooks
  84. Hallmarks of Metastasis: Molecular Underpinnings
    Juan C. Gomez-Gelvez, Dhananjay Arun Chitale · 2022 · Springer eBooks
  85. Data from iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration
    Tolga Turan, Sarah Kongpachith, Kyle D. Halliwill, Robert T. McLaughlin, Mikhail Binnewies, Dhemath Reddy, Xi Zhao, Rebecca S. Mathew, Shiming Ye, Howard J. Jacob et al. · 2023
  86. High Expression of C-C Chemokine Receptor Type 5 in Urothelial Carcinoma When Compared to Other Common Malignancies Based on a Novel, Quantitative Immunohistochemistry Assay and Scoring System From FFPE Tissue not Requiring Antigen Retrieval
    Shaheen Riadh Alanee · 2023 · Medical Research Archives
  87. Author Response: Telomere length sensitive regulation of Interleukin Receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment
    Ananda Kishore Mukherjee, Subhajit Dutta, Ankita Singh, Shalu Sharma, Shuvra Shekhar Roy, Antara Sengupta, Megha Chatterjee, Soujanya Vinayagamurthy, Sulochana Bagri, Divya Khanna et al. · 2024 · eLife
  88. Telomere length sensitive regulation of Interleukin Receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment
    Ananda Kishore Mukherjee, Subhajit Dutta, Ankita Singh, Shalu Sharma, Shuvra Shekhar Roy, Antara Sengupta, Megha Chatterjee, Soujanya Vinayagamurthy, Sulochana Bagri, Divya Khanna et al. · 2024 · eLife
  89. Inmunología de las enfermedades alérgicas e inmunitarias
    Andrej A. Petrov, Philip Fireman · 2007 · Elsevier eBooks
  90. Rol de la inflamación sistémica en la patología generada por tumores murinos
    Juan Bruzzo · 2014
  91. Chemokine Signaling: The Functional Importance of Stabilizing Receptor Conformations
    José Miguel Rodrı́guez-Frade, Antonio Serrano, Carlos Martínez‐A, Mario Mellado · 2005 · Springer eBooks
  92. Caractérisation moléculaire et fonctionnelle des lymphocytes T CD8+/CD103+ infiltrant les tumeurs pulmonaires humaines
    Brahim Fayçal Djenidi · 2014
  93. Role of dipeptidyl peptidase-4 in the regulation of leucocyte trafficking in hepatocellular carcinoma
    Clémence Hollande · 2017
  94. Mathematical modeling of tumor-immune system interactions : equilibrium and escape phase
    Kevin Atsou · 2020
  95. Synthesis and Evaluation of Anibamine and Its Analogs as Novel Anti-Prostate Cancer Agents
    Kendra M. Haney · 2009 · VCU Scholars Compass (Virginia Commonwealth University)
  96. In-vitro- und in-vivo-Hemmung des AKT-Signalweges in Melanomzellen durch einen neuen kleinmolekularen Inhibitor
    Schneider, Philine · 2013
  97. Microbial and maternal influences on allergic sensitization during childhood: defining a role for monocytes
    Shanie Saghafian‐Hedengren · 2009
  98. Gene-Modified Tumor-Cell Vaccines
    Leisha A. Emens, Elizabeth M. Jaffee · 2004 · Humana Press eBooks